CCPA Submits Comments to FDA on Peptide Compounding
CCPA Submits Comments to FDA on Peptide Compounding The Chronic Care Policy Alliance (CCPA) submitted comments to the FDA’s Pharmacy Compounding Advisory Committee regarding nomination of several peptide substances for…
CCPA Submits Comment Letter to CMS on Proposed Interoperability Standards and Prior Authorization for Drugs rule
On June 15, 2026, Chronic Care Policy Alliance (CCPA) submitted comments to the Centers for Medicare & Medicaid Services (CMS) on the proposed Interoperability Standards and Prior Authorization for Drugs…
Denied — but Not Defeated: Appeals Help Patients Access Care
Many patients know the sinking feeling when they learn a prescription, a specialist visit, a diagnostic test, or an ongoing treatment won’t be covered. Insurance denials are a growing barrier…
